January 13, 2026 - 03:02

San Francisco—Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. CEO Chris Boerner, Ph.D., emphasized that “business development remains a top priority” for the company’s capital allocation strategy as they move towards 2026. This focus on expanding their portfolio reflects the company's commitment to innovation and addressing unmet medical needs.
The pharmaceutical giant is actively seeking new opportunities for collaboration and acquisition, which Boerner believes will enhance their research and development capabilities. By casting a "broad net," Bristol Myers Squibb aims to identify potential partnerships that align with their strategic goals. This proactive approach is designed to ensure a robust pipeline of therapies that can significantly impact patient outcomes.
As the healthcare landscape evolves, the company remains dedicated to leveraging its resources effectively to bring transformative treatments to market. With a clear vision for the future, Bristol Myers Squibb is poised to make significant strides in the pharmaceutical industry.
April 19, 2026 - 09:00
Search intensifies for missing Oakland mother and business ownerThe search for an Oakland mother and prominent local business owner has entered a critical phase as she approaches a full month since her disappearance. Family, friends, and concerned citizens are...
April 18, 2026 - 23:00
What’s in a Name? When It Comes to Family Business, EverythingIn the world of family enterprise, a name is far more than a simple identifier on a storefront. It is the embodiment of generations of hard work, a vessel for shared values, and the very foundation...
April 18, 2026 - 07:17
Central Texas business owners looking for answers after closure of Painted Tree boutiquesThe unexpected nationwide shutdown of Painted Tree Boutiques has sent shockwaves through the small business community in Central Texas and beyond, leaving dozens of local artisans and vendors in a...
April 17, 2026 - 19:41
Berkshire Hathaway’s Big Utility Business Could Be Worth Close to $100 BillionBerkshire Hathaway`s sprawling utility business, a cornerstone of Warren Buffett`s conglomerate, is now estimated to be worth close to $100 billion. This immense valuation highlights the quiet but...